Zobrazeno 1 - 10
of 83
pro vyhledávání: '"J. A. M. Smith"'
Autor:
Y. Li, S. Morris, J. Cole, S. Dube’, J. A. M. Smith, C. Burbridge, T. Symonds, S. Hudgens, W. Wang
Publikováno v:
BMC Musculoskeletal Disorders, Vol 18, Iss 1, Pp 1-12 (2017)
Abstract Background The Multidimensional Daily Diary of Fatigue-Fibromyalgia-17 instrument (MDF-Fibro-17) has been developed for use in fibromyalgia (FM) clinical studies and includes 5 domains: Global Fatigue Experience, Cognitive Fatigue, Physical
Externí odkaz:
https://doaj.org/article/7c1fb083ea074491b3c48ceb9f5d14ae
Publikováno v:
Association ICCHP
Document recommendation systems for locating relevant literature have mostly relied on methods developed a decade ago. This is largely due to the lack of a large offline gold-standard benchmark of relevant documents that cover a variety of research f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::3883df6a9b857b1fe020dcaa348695c3
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106365
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106365
Autor:
Stephen Morris, W. Wang, J. Cole, S. Dube, C. Burbridge, J. A. M. Smith, Y. Li, T. Symonds, S. Hudgens
Publikováno v:
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders, Vol 18, Iss 1, Pp 1-12 (2017)
BMC Musculoskeletal Disorders, Vol 18, Iss 1, Pp 1-12 (2017)
Background The Multidimensional Daily Diary of Fatigue-Fibromyalgia-17 instrument (MDF-Fibro-17) has been developed for use in fibromyalgia (FM) clinical studies and includes 5 domains: Global Fatigue Experience, Cognitive Fatigue, Physical Fatigue,
Publikováno v:
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders, Vol 18, Iss 1, Pp 1-8 (2017)
BMC Musculoskeletal Disorders, Vol 18, Iss 1, Pp 1-8 (2017)
Background Fibromyalgia (FM), a disorder characterized by chronic widespread pain and tenderness, affects greater than five million individuals in the United States alone. Patients experience multiple symptoms in addition to pain, and among them, fat
Autor:
Mike Ero, Kathryn Kersey, J A M Smith, R G Vickery, S.M. Amagasu, A. Hopkins, D.L. Higgins, D.T. Beattie
Publikováno v:
Vascular Pharmacology. 58:150-156
The 5-HT(4) receptor agonists, and gastrointestinal (GI) prokinetic agents, cisapride and tegaserod, lack selectivity for the 5-HT(4) receptor. Cisapride is a potent human ether-à-go-go-related gene (hERG) potassium channel inhibitor while cisapride
Publikováno v:
Molecular Pharmacology. 79:389-399
Biphenyl-2-yl-carbamic acid 1-{9-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydro-quinolin-5-yl)-ethylamino]-nonyl}-piperidin-4-yl ester (THRX-198321) is a single molecule composed of a muscarinic acetylcholine receptor (mAChR) antagonist moiety, repres
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 378:125-137
The in vitro pharmacological profile of TD-5108, a novel, selective 5-HT(4) receptor agonist, was compared to that of clinically efficacious gastroprokinetic 5-HT(4) receptor agonists. TD-5108 produced an elevation of cyclic adenosine monophosphate i
Autor:
Patrick P.A. Humphrey, J A M Smith, D. Marquess, J. A. Taylor, C. Sandlund, J.-P. Shaw, David Beattie, Scott R. Armstrong
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 378:139-147
The in vivo preclinical pharmacodynamic profile of TD-5108, a selective 5-HT4 receptor agonist with high intrinsic activity, was compared to that of the clinically studied gastrointestinal pro-kinetic agents, tegaserod, cisapride and mosapride. The a